{"filter":{"intervention":"phage_therapy"},"n_projects":4,"projects":[{"accession":"PRJEB50555","age_categories":{"adult":537},"countries":{"DE":22,"FR":76,"IL":73,"US":52},"first_public_year":"2022","gbp_per_sample_median":24.13,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"crohns_disease":83,"healthy_control":56,"ulcerative_colitis":85},"intervention_design":"single_arm_before_after","intervention_detail":"Oral five-phage combination targeting IBD-associated Klebsiella pneumoniae in healthy volunteers","interventions":["phage_therapy"],"n_samples":537,"papers":[{"doi":"10.3390/microorganisms12102086","pmcid":"PMC11510655","pmid":"39458395","title":"Oral Microbial Translocation Genes in Gastrointestinal Cancers: Insights from Metagenomic Analysis."}],"sample_intervention_arms":{},"sex":{},"title":"Targeted suppression of human IBD-associated gut microbiota commensals for treatment of intestinal inflammation","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB50555","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB50555_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB50555.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB50555.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB50555.csv.gz"}},{"accession":"PRJNA1220341","age_categories":{"unknown":391},"countries":{"US":391},"first_public_year":"2026","gbp_per_sample_median":16.7,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":391},"intervention_design":"randomized_controlled_trial","intervention_detail":"CRISPR-armed phage cocktail (SNIPR001) vs placebo, twice daily 7 days, 3 doses","interventions":["phage_therapy"],"n_samples":391,"papers":[{"doi":"10.1016/j.lanmic.2025.101257","pmcid":null,"pmid":"41785880","title":"Safety, recovery, and pharmacodynamics of CRISPR-Cas therapeutic SNIPR001: a phase 1, randomised, double-blind, first-in-human, dose-escalation study."}],"sample_intervention_arms":{"phage_therapy":260,"placebo":131},"sex":{},"title":"Human gut microbiome during treatment with CRISPR-armed phages (SNIPR001) or placebo","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1220341","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1220341_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1220341.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1220341.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1220341.csv.gz"}},{"accession":"PRJNA866369","age_categories":{"unknown":18},"countries":{"CN":18},"first_public_year":"2023","gbp_per_sample_median":0.95,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"non_randomized_controlled","intervention_detail":"In vitro fecal batch culture with phage cocktail vs heat-killed phage","interventions":["phage_therapy"],"n_samples":18,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"The metagenomic data of 18 samples of human feces with a 24-hours batch culture in vitro","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA866369","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA866369_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA866369.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA866369.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA866369.csv.gz"}},{"accession":"PRJNA732769","age_categories":{"adult":9},"countries":{"CA":9},"first_public_year":"2021","gbp_per_sample_median":0.09,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"ulcerative_colitis":5},"intervention_design":"non_randomized_controlled","intervention_detail":"Fecal VLP (phage) transplant from UC patients or healthy controls into HMA mice, +/- DSS colitis","interventions":["fmt","phage_therapy"],"n_samples":9,"papers":[{"doi":"10.1186/s40168-022-01275-2","pmcid":"PMC9264660","pmid":"35799219","title":"Transplantation of bacteriophages from ulcerative colitis patients shifts the gut bacteriome and exacerbates the severity of DSS colitis."}],"sample_intervention_arms":{},"sex":{},"title":"The impact of bacteriophages on DSS-colitis and microbiota composition - VLP shotgun","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA732769","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA732769_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA732769.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA732769.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA732769.csv.gz"}}],"release":"R2026.25"}